Thermo Fisher Scientific Inc Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| DHR | Danaher Corp | Outperform |
10
|
$269.85 | $304.24 | 12.84% | 1 | $193.71B |
| A | Agilent Technologies | Outperform |
17
|
$154.55 | $162.50 | 7.73% | 15 | $43.72B |
| ILMN | Illumina Inc | Outperform |
16
|
$214.26 | $254.08 | 16.45% | 14 | $31.19B |
| WAT | Waters Corp | Hold |
15
|
$341.39 | $336.44 | -0.41% | 9 | $16.21B |
| PKI | PerkinElmer | Outperform |
16
|
$138.56 | $159.83 | 17.28% | 4 | $16.87B |
| AVTR | Avantor | Buy |
16
|
$23.05 | $0.00 | 95.23% | 1 | $13.53B |
| BIO | Bio-Rad Laboratories | Buy |
16
|
$470.88 | $588.75 | 23.70% | 0 | $12.42B |
| BRKR | Bruker | Outperform |
16
|
$72.52 | $72.11 | 3.42% | 2 | $9.91B |
| COHR | Coherent | Hold |
12
|
$266.22 | $255.33 | 7.95% | 1 | $6.61B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$11.58 | $17.33 | 42.49% | 0 | $1.17B |
| FLDM | Fluidigm | - |
11
|
$20.28 | $12.00 | -91.27% | 0 | $157.59M |
| HBIO | Harvard Bioscience | Buy |
14
|
$2.89 | $10.00 | 246.02% | 0 | $145.58M |
| EQTL | Equitech International | - |
0
|
$2.00 | $0.00 | -100.00% | 0 | $3.14M |
| OMRX | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
| LFPI | LifePoint | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
| MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| MTD | Mettler-Toledo International I... | Hold |
13
|
$1.56k | $1.39k | -12.38% | 0 | $0.00M |
| ASPT | Haber | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |